Vivomixx neo® 115 - Gélule
Food supplement declared in France, decision dated 17 March 2025
Vivomixx neo® 115 - Gélule, from ELLIS PHARMA S.R.L., is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Lactobacillus Paracasei IMC 502 47,500,000,000 (unit not declared) per day, Lacticaseibacillus Rhamnosus IMC 501 47,500,000,000 (unit not declared) per day, Lacticaseibacillus Rhamnosus SP1 6,500,000,000 (unit not declared) per day, Bifidobacterium Animalis BLC1 2,250,000,000 (unit not declared) per day, Bifidobacterium Breve BBR 8 2,250,000,000 (unit not declared) per day. None of the rules we check flags an issue with its declared composition.
- Brand
- Vivomixx neo®
- Food business operator placing the product on the market
- ELLIS PHARMA S.R.L.
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 1 à 4 gélules / jour
- Directions for use
- Avaler la capsule avec un verre de 100 ml d’eau
- Intended populations
- General population
- Not recommended (according to the manufacturer)
- Young children (aged 1 to 3)
- Objectives stated by the manufacturer (these are not authorised claims)
- Bowel regularity, Digestion
Declaration 145749, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Micro-organisms
| Strain | Per day |
|---|---|
| Lactobacillus Paracasei IMC 502 | 47,500,000,000 (unit not declared) |
| Lacticaseibacillus Rhamnosus IMC 501 | 47,500,000,000 (unit not declared) |
| Lacticaseibacillus Rhamnosus SP1 | 6,500,000,000 (unit not declared) |
| Bifidobacterium Animalis BLC1 | 2,250,000,000 (unit not declared) |
| Bifidobacterium Breve BBR 8 | 2,250,000,000 (unit not declared) |
| Lactococcus Lactis SP38 | 2,250,000,000 (unit not declared) |
| Lactobacillus Acidophilus LA1 | 2,250,000,000 (unit not declared) |
| Lactobacillus Plantarum 14D | 2,250,000,000 (unit not declared) |
| Streptococcus Thermophilus SP4 | 2,250,000,000 (unit not declared) |
Additives
E460, E470b
Other ingredients
Gélule végétale, amidon de maïs
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : Vivomixx neo®
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Vivomixx neo® 115 - Gélule: composition and regulation”, https://compoatlas.com/en/supplements/products/145749-vivomixx-neo-115-gelule, updated 15 November 2026.